Triple
T2423466
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | NIDA Drug Supply Program |
E53471
|
entity |
| Predicate | administeredBy |
P86
|
FINISHED |
| Object |
NIDA Division of Therapeutics and Medical Consequences
The NIDA Division of Therapeutics and Medical Consequences is a branch of the National Institute on Drug Abuse that oversees research and development of treatments and medical interventions related to substance use and its health impacts.
|
E265653
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NIDA Division of Therapeutics and Medical Consequences | Statement: [NIDA Drug Supply Program, administeredBy, NIDA Division of Therapeutics and Medical Consequences]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: NIDA Division of Therapeutics and Medical Consequences Context triple: [NIDA Drug Supply Program, administeredBy, NIDA Division of Therapeutics and Medical Consequences]
-
A.
NIDA International Program
NIDA International Program is a global initiative of the U.S. National Institute on Drug Abuse that fosters international collaboration in drug abuse research, training, and policy.
-
B.
NIDA Notes
NIDA Notes is a publication of the National Institute on Drug Abuse that reports on research findings and developments related to drug use, addiction, and their prevention and treatment.
-
C.
NIDA Drug Supply Program
The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.
-
D.
National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
E.
Advisory Council on the Misuse of Drugs
The Advisory Council on the Misuse of Drugs is an independent expert body in the United Kingdom that advises the government on drug-related issues, including classification, harms, and policy.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: NIDA Division of Therapeutics and Medical Consequences Triple: [NIDA Drug Supply Program, administeredBy, NIDA Division of Therapeutics and Medical Consequences]
Generated description
The NIDA Division of Therapeutics and Medical Consequences is a branch of the National Institute on Drug Abuse that oversees research and development of treatments and medical interventions related to substance use and its health impacts.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: NIDA Division of Therapeutics and Medical Consequences Target entity description: The NIDA Division of Therapeutics and Medical Consequences is a branch of the National Institute on Drug Abuse that oversees research and development of treatments and medical interventions related to substance use and its health impacts.
-
A.
NIDA International Program
NIDA International Program is a global initiative of the U.S. National Institute on Drug Abuse that fosters international collaboration in drug abuse research, training, and policy.
-
B.
NIDA Notes
NIDA Notes is a publication of the National Institute on Drug Abuse that reports on research findings and developments related to drug use, addiction, and their prevention and treatment.
-
C.
NIDA Drug Supply Program
The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.
-
D.
National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
E.
Advisory Council on the Misuse of Drugs
The Advisory Council on the Misuse of Drugs is an independent expert body in the United Kingdom that advises the government on drug-related issues, including classification, harms, and policy.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ab495c44d48190b7235b23719bc3f6 |
completed | March 6, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69abc972934481909e05bd6f31162f9d |
completed | March 7, 2026, 6:45 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69aebf5e33208190a6899e6672b3daeb |
completed | March 9, 2026, 12:38 p.m. |
| NEDg | Description generation | batch_69aec590516c81908f5126e203bb3638 |
completed | March 9, 2026, 1:05 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69aec6194a3c81909055a16553f39e78 |
completed | March 9, 2026, 1:07 p.m. |
Created at: March 6, 2026, 9:42 p.m.